Shanghai Xitaili Biomedicine Technology Co., Ltd.

This early-stage trial tests a new injection called XTL6001 in 80 healthy and obese adults. The main goal is to check safety and how the body processes the drug. Researchers will also look at weight changes, but the study is too small to prove effectiveness.